PFIZER INC Increase (Decrease) in Operating Capital
PFIZER INC (PFE) reported Increase (Decrease) in Operating Capital of $3.55 billion for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-08-04
- PFIZER INC increase (decrease) in operating capital for the quarter ending 2026-06-28 was $1.82B, a 63.60% decline year-over-year.
- PFIZER INC increase (decrease) in operating capital for the quarter ending 2026-03-29 was $1.73B, a 9.74% decline year-over-year.
- PFIZER INC increase (decrease) in operating capital for the quarter ending 2025-09-28 was $36.00M.
- PFIZER INC increase (decrease) in operating capital for the quarter ending 2025-06-29 was $4.99B, a 41.13% increase year-over-year.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 3 month as first filed | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 6 month as first filed | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-28 | $1.82B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.55B 10-Q · filed 2026-08-04 | ||||
| 2026-03-29 | $1.73B 10-Q · filed 2026-05-05 | |||||
| 2025-09-28 | $36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.03B derived: sum of 2 quarters · filed 2026-08-04 | $6.94B 10-Q · filed 2025-11-04 | |||
| 2025-06-29 | $4.99B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.91B 10-Q · filed 2026-08-04 | ||||
| 2025-03-30 | $1.92B 10-Q · filed 2026-05-05 | |||||
| 2024-09-29 | -$879.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.66B derived: sum of 2 quarters · filed 2025-11-04 | $5.99B 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | $3.54B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $6.87B 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | $3.34B 10-Q · filed 2025-05-05 | |||||
| 2023-10-01 | $1.20B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $5.12B derived: sum of 2 quarters · filed 2024-11-04 | $10.62B 10-Q · filed 2024-11-04 | |||
| 2023-07-02 | $3.92B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $9.42B 10-Q · filed 2024-08-05 | ||||
| 2023-04-02 | $5.51B 10-Q · filed 2024-05-08 | |||||
| 2022-10-02 | $4.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $7.35B derived: sum of 2 quarters · filed 2023-11-08 | $8.08B 10-Q · filed 2023-11-08 | $7.61B 10-Q · filed 2022-11-09 | ||
| 2022-07-03 | $2.77B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.50B 10-Q · filed 2023-08-09 | ||||
| 2022-04-03 | $730.00M 10-Q · filed 2023-05-10 | |||||
| 2021-10-03 | -$6.76B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$12.15B derived: sum of 2 quarters · filed 2022-11-09 | -$10.87B 10-Q · filed 2022-11-09 | -$10.82B 10-Q · filed 2021-11-12 | ||
| 2021-07-04 | -$5.38B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$4.10B 10-Q · filed 2022-08-10 | -$4.40B 10-Q · filed 2021-08-12 | |||
| 2021-04-04 | $1.28B 10-Q · filed 2022-05-11 | $1.33B 10-Q · filed 2021-05-13 | ||||
| 2020-09-27 | $800.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.34B derived: sum of 2 quarters · filed 2021-11-12 | $2.86B 10-Q · filed 2021-11-12 | $3.08B 10-Q · filed 2020-11-05 | ||
| 2020-06-28 | $541.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.06B 10-Q · filed 2021-08-12 | $2.23B 10-Q · filed 2020-08-06 | |||
| 2020-03-29 | $1.51B 10-Q · filed 2021-05-13 | $1.58B 10-Q · filed 2020-05-07 | ||||
| 2019-09-29 | -$1.48B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.07B derived: sum of 2 quarters · filed 2020-11-05 | $5.57B 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $3.55B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $7.05B 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | $3.50B 10-Q · filed 2020-05-07 | |||||
| 2018-09-30 | -$809.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$274.00M derived: sum of 2 quarters · filed 2019-11-07 | $2.44B 10-Q · filed 2019-11-07 | |||
| 2018-07-01 | $535.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $3.25B 10-Q · filed 2019-08-08 | ||||
| 2018-04-01 | $2.71B 10-Q · filed 2019-05-09 | |||||
| 2017-10-01 | -$228.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.40B derived: sum of 2 quarters · filed 2018-11-08 | $3.62B 10-Q · filed 2018-11-08 | $3.64B 10-Q · filed 2017-11-09 | ||
| 2017-07-02 | $1.63B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.84B 10-Q · filed 2018-08-09 | $3.85B 10-Q · filed 2017-08-10 | |||
| 2017-04-02 | $2.22B 10-Q · filed 2018-05-10 | $2.23B 10-Q · filed 2017-05-11 | ||||
| 2016-10-02 | -$1.60B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$543.00M derived: sum of 2 quarters · filed 2017-11-09 | $1.58B 10-Q · filed 2017-11-09 | $1.72B 10-Q · filed 2016-11-10 | ||
| 2016-07-03 | $1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $3.18B 10-Q · filed 2017-08-10 | $3.32B 10-Q · filed 2016-08-11 | |||
| 2016-04-03 | $2.13B 10-Q · filed 2017-05-11 | $2.26B 10-Q · filed 2016-05-12 | ||||
| 2015-09-27 | -$582.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$586.00M derived: sum of 2 quarters · filed 2016-11-10 | $1.30B 10-Q · filed 2016-11-10 | $1.29B 10-Q · filed 2015-11-05 | ||
| 2015-06-28 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.88B 10-Q · filed 2016-08-11 | $1.87B 10-Q · filed 2015-08-06 | |||
| 2015-03-29 | $1.88B 10-Q · filed 2016-05-12 | $1.88B 10-Q · filed 2015-05-07 | ||||
| 2014-09-28 | -$430.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $428.00M derived: sum of 2 quarters · filed 2015-11-05 | $1.52B 10-Q · filed 2015-11-05 | |||
| 2014-06-29 | $858.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.95B 10-Q · filed 2015-08-06 | ||||
| 2014-03-30 | $1.09B 10-Q · filed 2015-05-07 | |||||
| 2013-09-29 | -$715.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.42B derived: sum of 2 quarters · filed 2014-11-06 | $4.75B 10-Q · filed 2014-11-06 | $4.31B 10-Q · filed 2013-11-08 | ||
| 2013-06-30 | $2.14B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $5.46B 10-Q · filed 2014-08-07 | $5.27B 10-Q · filed 2013-08-09 | |||
| 2013-03-31 | $3.33B 10-Q · filed 2014-05-08 | $3.39B 10-Q · filed 2013-05-10 | ||||
| 2012-09-30 | $417.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.81B derived: sum of 2 quarters · filed 2013-11-08 | $3.34B 10-Q · filed 2013-11-08 | $3.51B 10-Q · filed 2012-11-09 | ||
| 2012-07-01 | $1.39B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.92B 10-Q · filed 2013-08-09 | $3.04B 10-Q · filed 2012-08-09 | |||
| 2012-04-01 | $1.53B 10-Q · filed 2013-05-10 | $1.56B 10-Q · filed 2012-05-10 | ||||
| 2011-10-02 | $361.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $624.00M derived: sum of 2 quarters · filed 2012-11-09 | $102.00M 10-Q · filed 2012-11-09 | $326.00M 10-Q · filed 2011-11-10 | ||
| 2011-07-03 | $263.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$259.00M 10-Q · filed 2012-08-09 | -$187.00M 10-Q · filed 2011-08-11 | |||
| 2011-04-03 | -$522.00M 10-Q · filed 2012-05-10 | |||||
| 2010-10-03 | -$2.66B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$1.70B derived: sum of 2 quarters · filed 2011-11-10 | $10.51B 10-Q · filed 2011-11-10 | |||
| 2010-07-04 | $959.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $13.17B 10-Q · filed 2011-08-11 | ||||
| 2010-04-04 | $11.98B 10-Q · filed 2011-05-12 | $11.82B 10-Q · filed 2010-05-13 | ||||
| 2009-09-27 | $593.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | -$59.00M derived: sum of 2 quarters · filed 2010-11-12 | $840.00M 10-Q · filed 2010-11-12 | $522.00M 10-Q · filed 2009-11-05 | ||
| 2009-06-28 | -$652.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $247.00M 10-Q · filed 2010-08-12 | -$247.00M 10-Q · filed 2009-08-06 | |||
| 2009-03-29 | $899.00M 10-Q · filed 2010-05-13 | |||||
| 2008-09-28 | $3.17B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $1.54B 10-Q · filed 2009-11-05 | ||||
| 2008-06-29 | -$1.63B 10-Q · filed 2009-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |